TABLE 1.
Baseline Characteristics of Study Participants with Chronic Lower-Extremity Wounds in Southeastern Michigan, 2011
| Characteristic | Participants |
|---|---|
| Age, years, median (range) | 57 (27–93) |
| Sex (n = 179) | |
| Male | 109 (61) |
| Female | 70 (39) |
| Race (n = 176) | |
| Black | 100 (57) |
| White | 72 (41) |
| Other/unknown/decline to state | 4 (2) |
| Annual household income (n = 172) | |
| $25,000 or less | 57 (33) |
| Greater than $25,000 | 46 (27) |
| Decline to state | 69 (40) |
| Employment (n = 179) | |
| Employed | 25 (14) |
| Unemployed | 154 (86) |
| Education (n = 172) | |
| High school education or less | 90 (52) |
| Education beyond high school | 82 (48) |
| Functional disability (n = 179) | |
| Any disability | 49 (27) |
| No functional disability | 130 (73) |
| Medical comorbidities (n = 179) | |
| Diabetes | 81 (45) |
| Current smoker | 47 (26) |
| Peripheral vascular disease | 43 (24) |
| Congestive heart failure | 37 (21) |
| History of myocardial infarction | 28 (16) |
| End-stage renal disease | 9 (5) |
| Charlson comorbidity index score (n = 179) | |
| 0 | 43 (24) |
| 1–3 | 96 (54) |
| 4–6 | 20 (11) |
| 7–12 | 19 (11) |
| >12 | 1 (1) |
| Duration of chronic wounds (potentially different, sequential wounds; n = 179) | |
| <3 months | 33 (18) |
| 3–6 months | 30 (17) |
| >6 months to 12 months | 23 (13) |
| >12 months to 2 years | 20 (11) |
| >2 years | 73 (41) |
| Indwelling devices in the previous 3 months (n = 177) | |
| Any | 47 (26) |
| Central venous catheter | 37 (21) |
| Other devices (eg, urinary catheter and PEG) | 17 (10) |
| Healthcare exposure | |
| Ever hospitalized (n = 178) | 161 (90) |
| 2 hospitalizations in the previous 12 months (n = 155) | 63 (41) |
| Hospitalized in the previous 3 months (n = 177) | 61 (34) |
| Ever stay in a long-term care facility (n = 177) | 43 (24) |
| Long-term care facility in the previous 3 months (n = 160) | 15 (9) |
| Antimicrobials in the previous 3 months (n = 179) | |
| Any | 122 (68) |
| Vancomycin | 46 (26) |
| Daptomycin | 2 (1) |
| Linezolid | 1 (1) |
| Penicillin | 2 (1) |
| β-lactam/β-lactamase inhibitor combinations | 16 (9) |
| Cephalosporin | 45 (25) |
| Carbapenem | 6 (3) |
| Aminoglycoside | 1 (1) |
| Macrolide | 5 (3) |
| Trimethoprim-sulfamethoxazole | 35 (20) |
| Clindamycin | 10 (6) |
| Tetracycline | 3 (2) |
| Fluoroquinolone | 33 (18) |
NOTE. Data are no. (%) of patients, unless otherwise indicated. PEG, percutaneous endoscopic gastrostomy.